Research summaries for everyoneNot medical advice
Selank research reference vial, Elevated Pharma

Research reference · Cognition & Sleep

Selank

Selank is a synthetic heptapeptide based on tuftsin. Most of its literature comes from Russian research groups, with a few small clinical studies in anxiety.

Published by Elevated Pharma ·

Cognition & SleepPreclinical and analytical literature

Identity

What is Selank?

A synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Research context

What has Selank been studied for?

Animal work covers anxiety, stress and memory models; small Russian clinical studies examine anxiety disorders.

Evidence boundary

What does the research not show?

Small, mostly non-Western studies do not establish human safety or effectiveness by current standards.

U.S. status · November 7, 2026

Is Selank FDA-approved?

Not FDA-approved. Selank was not on FDA’s 2026 compounding advisory agendas.

Key studies

The main Selank research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 68 PubMed records for Selank · Counts and selections checked November 7, 2026.

Reference identifiers

Selank identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
Selank
Also indexed as
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular formula
C33H57N11O9
Molecular mass
751.9 g/mol
PubChem CID
11765600

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.